Sera Prognostics director executes 10b5-1 sale; 18,814 shares remain
Rhea-AI Filing Summary
Sera Prognostics director Sandra AJ Lawrence reported the sale of 3,899 shares of Class A common stock on 09/09/2025 under a Rule 10b5-1 trading plan adopted June 10, 2025. The shares were sold in multiple transactions at prices ranging from $2.99 to $3.12, with a reported weighted-average price of $3.05. After the reported dispositions, the reporting person beneficially owns 18,814 shares. The Form 4 was signed by an attorney-in-fact, Benjamin G. Jackson.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director sold a small block under a pre-established 10b5-1 plan; procedural disclosure appears complete and routine.
The sale of 3,899 shares was executed pursuant to a Rule 10b5-1 plan adopted June 10, 2025, which indicates the transactions were pre-authorized. The filer remains a director and retains 18,814 shares after the sale. The Form 4 discloses the weighted-average sale price and the price range for the multiple transactions, and the filing includes an attorney-in-fact signature. There are no indications of undisclosed related-party transactions or departures from standard Section 16 reporting protocols in the document provided.
TL;DR: Transaction is a routine insider sale under a 10b5-1 plan; no new material operational or financial information disclosed.
The reported disposition reduces the reporting person's stake to 18,814 shares; the sale prices ranged from $2.99 to $3.12 with a weighted average of $3.05. The filing does not include any derivative transactions or additional material disclosures about the issuer's performance. From a market-impact perspective, the disclosed sale size and details suggest a routine liquidity event rather than a material corporate development.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 3,899 | $3.05 | $12K |
Footnotes (1)
- The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.99 to $3.12, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.